Targeted Single-Cell Solutions for High Impact Applications.

When you study or treat cancer, you don’t want to miss a single cell. Any cell that remains after treatment can lead to relapse. Mission Bio’s Tapestri^® Platform is the only technology that provides single-cell targeted DNA sequencing at single-base resolution.

SEE HOWMeet tapestri

Moving precision medicine FORWARD.

“

"No technology prior to Tapestri has been able to give us the resolution to decipher co-occurring mutations in the same clones. These insights are especially important in our study of resistance mechanisms and combinatorial therapies in key clinical trials."

- Catherine Smith, MD
“

“To accelerate the understanding of response, resistance, and relapse, it is important to move away from bulk sequencing and make single-cell analysis routine.”

- Jerry Radich, MD
“

"This new capability of single-cell analysis is critical to better understanding precision therapy selection at diagnosis as well as disease monitoring and subsequent treatment strategy.”

- Koichi Takahashi, MD
“

"We use cutting edge single-cell techniques like the Tapestri Platform to give us insights into the selective advantages certain mutations confer in hematopoietic stem and progenitor cells, along with examining clonal heterogeneity including in the detection of minimal residual disease."

- Ross Levine, MD
“

"We have a profound gap in knowledge between the interaction of a person, their cancer, and their therapy and how that impacts response. We need better insight."

- Jerry Radich, MD

See What You’re Missing

The promise of precision medicine is to deliver highly targeted treatment to every single diseased cell. The current one-size-fits-all approach of medical treatments isn’t working for many patients who need help. To move precision medicine forward, researchers and clinicians need to look at the origins of disease — the single cell — in meaningful new ways.

Learn More

The Tapestri Platform delivers targeted solutions for high-impact application areas, including blood cancers, solid tumors, and genome editing validation.

Hematology

Solid Tumor

Genome Editing

Tapestri®

The Precision Genomics Platform™

Tapestri is the industry’s first targeted single-cell DNA sequencing platform, enabling precise detection of heterogeneity in disease progression and treatment response. The platform includes an instrument, consumables, and analysis software, which integrate seamlessly with existing NGS workflows. With Tapestri, researchers have a highly sensitive, targeted, and customizable solution to move precision medicine forward.

Meet Tapestri